Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $73.5M invested in Avalo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
3
Reduced
4
Closed
6
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
1 |
AC
Armistice Capital
New York
|
+$1.58M |
2 |
Invesco
Atlanta,
Georgia
|
+$327K |
3 |
SIM
Spark Investment Management
New York
|
+$288K |
4 |
BlackRock
New York
|
+$108K |
5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$64K |
Top Sellers
1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.11M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$334K |
3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$229K |
4 |
VF
Virtu Financial
New York
|
-$103K |
5 |
Citadel Advisors
Miami,
Florida
|
-$86K |